Kesimpta 20 MG/0.4 ML pen 0.4ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9V51
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,215
Award facts
- Contract value 100% obligated
- $14,214.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $14,214.58 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 7, 2026, for the supply of Kesimpta 20 mg/0.4 mL pen injectors. The order, with an ultimate completion date of January 8, 2026, represents a child contract under the parent entity Cencora, Inc. (doing business as AmerisourceBergen). The place of performance is Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order was competitively awarded with no set-aside designation, reflecting the company's demonstrated capability to meet federal pharmaceutical procurement requirements through open competition.
This delivery order is executed under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (valued at up to $999,999,999.00 through December 2026), which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. The IDC enables the company to supply specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. Kesimpta, a monoclonal antibody treatment for relapsing multiple sclerosis, aligns with the broad therapeutic range covered under this prime vendor contract framework.
Quick answers
Who was awarded contract SPE2DR26F9V51?
SPE2DR26F9V51 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26F9V51 worth?
The government has obligated $14,215 on SPE2DR26F9V51.
Is contract SPE2DR26F9V51 an order under another contract?
Yes. SPE2DR26F9V51 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9V51 competed?
The extent of competition for SPE2DR26F9V51 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award